1 documents found
Information × Registration Number 0120U104538, R & D request Title Comparative study of the efficacy and safety of PB006 (bioanalysis of natalizumab) and Tisabri in the treatment of patients with recurrent relapsing multiple sclerosis (RRRS) (code code Antelope) Head Lytvynenko Nataliia V., Доктор медичних наук Registration Date 23-10-2020 Organization Ukrainian medical stomatological Academy popup.description1 study of the efficacy and safety of PB006 (bioanalysis of natalizumab) and Tisabri in the treatment of patients with recurrent relapsing multiple sclerosis popup.nrat_date 2024-12-10 Close
search.res_rk
Comparative study of the efficacy and safety of PB006 (bioanalysis of natalizumab) and Tisabri in the treatment of patients with recurrent relapsing multiple sclerosis (RRRS) (code code Antelope)
Head: Lytvynenko Nataliia V.. Comparative study of the efficacy and safety of PB006 (bioanalysis of natalizumab) and Tisabri in the treatment of patients with recurrent relapsing multiple sclerosis (RRRS) (code code Antelope). Ukrainian medical stomatological Academy. № 0120U104538
1 documents found

Updated: 2026-03-26


Роздрукувати цю сторінку